Quality assurance and the system as a whole
“Is the assessment genuinely cross-functional?”
Quality, validation, equipment qualification, regulatory dossier and quality agreements. The dossier question is the one most often missed.
Change control fails in two opposite directions — as a bottleneck the business routes around, or as a signature with no real assessment. Both look like a working process on paper.
Nothing should be implemented before the assessment that should have preceded it.
The requirement, the failure modes and the primary sources.
02 · AssessScore this domain and see where it sits against the others.
03 · PositionThe five levels, and the domains modelled so far.
04 · QuantifyTurn the current position into an annual carrying cost.
Quality assurance and the system as a whole
“Is the assessment genuinely cross-functional?”
Quality, validation, equipment qualification, regulatory dossier and quality agreements. The dossier question is the one most often missed.
Laboratory, testing and analytical data
“Does this affect a method, specification or stability commitment?”
Analytical changes frequently carry dossier implications that are invisible on the shop floor.
Production, process and the floor
“Can routine changes actually move?”
If minor changes queue behind the same committee as significant ones, the business will route around the process.
Certification and batch release
“Has anything changed that affects the basis for release?”
Including changes at contract sites, which should reach you through the quality agreement.
Requirements, dossier and authority expectations
“Does this require a variation?”
Implementing first and filing later converts a quality process into a regulatory problem.
The GMP Health Index scores seven quality-system domains and maps each to a maturity level. It calculates in your browser and keeps history on your device only.